How do you approach CNS prophylaxis for high risk DLBCL?

How do you consider amongst the options for route (IT vs IV), timing (intercalated vs EOT), and combination (dose-intensified, +MTX, AraC-containing regimens)? Given the recent data presented at ASH demonstrating a lack of risk reduction with MTX prophylaxis - will this change your practice and if so how?